Softwr

Healthcare · head to head

Fujifilm Synapse vs Signant Health

Fujifilm Synapse logo

Fujifilm Synapse

Healthcare

Enterprise imaging platform covering PACS, VNA, cardiology and 3D from Fujifilm Healthcare

From
On request
Rated
-
Full reviewWebsite
Signant Health logo

Signant Health

Healthcare

eCOA-first clinical trial platform that has grown outward into EDC, eConsent and televisits

From
On request
Rated
-
Full reviewWebsite

The short version

  • Each has a real cost: Fujifilm Synapse pACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.; Signant Health no pricing is published, and the software licence is a minority of the real bill once instrument licensing, translations, device provisioning and services are added, so early budget estimates are routinely too low.
  • They diverge on capability: Fujifilm Synapse covers Synapse PACS, Signant Health covers eCOA and ePRO.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Fujifilm Synapse and Signant Health actually diverge.

Attributes where Fujifilm Synapse and Signant Health differ
AttributeFujifilm SynapseSignant Health
PlatformsWeb, Windows, iOS, AndroidWeb, iOS, Android

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Fujifilm Synapse

  • Synapse PACS
  • Synapse VNA
  • Synapse Cardiovascular
  • Synapse 3D
  • Synapse Mobility
  • Deconstructed PACS support
  • Cloud services

Only in Signant Health

  • eCOA and ePRO
  • Unified platform
  • eConsent
  • Randomisation and supplies
  • TeleVisits
  • Rater training
  • Data surveillance
  • Instrument library

What people use each for

The jobs each tool is most often brought in to do.

Fujifilm Synapse

  • A hospital replacing PACS that wants the archive decoupled from its scanner vendor so future modality purchases stay competitivenot Signant Health
  • A health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policynot Signant Health
  • An outpatient imaging chain that needs one worklist across multiple sites and radiologists reading remotelynot Signant Health
  • A site pursuing a deconstructed PACS strategy that wants to replace the viewer later without touching the archivenot Signant Health

Signant Health

  • A central nervous system or psychiatry trial where the primary endpoint is a rated scale and rater consistency decides the readoutnot Fujifilm Synapse
  • A global study needing an outcome instrument translated and linguistically validated across a dozen languagesnot Fujifilm Synapse
  • A decentralised or hybrid protocol combining televisits, eConsent and at-home patient reported outcomesnot Fujifilm Synapse
  • A sponsor consolidating separate eCOA, eConsent and randomisation vendors onto one platform to cut reconciliation worknot Fujifilm Synapse

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Fujifilm Synapse

  • PACS, VNA, Cardiovascular and 3D are separately licensed and separately versioned, so an enterprise deployment means four upgrade cycles and four support relationships under one brand rather than one platform upgrade.
  • Synapse 3D is licensed by concurrent user and sized from average concurrency, which leaves radiologists queued for advanced visualisation at the morning reading peak and forces an unplanned licence purchase.
  • As an independent informatics vendor Fujifilm has less privileged access to proprietary modality data than Philips or Siemens have on their own scanners, so some vendor specific post processing is not available.
  • The vendor neutral archive absorbs non DICOM object types only after per specialty configuration work, and departments such as ophthalmology and dermatology usually need bespoke ingestion projects that were not in the original scope.
  • Migrating a decade of priors from a legacy archive is a large professional services line that Fujifilm quotes separately, and these migrations regularly run past the contracted go live date.

Signant Health

  • No pricing is published, and the software licence is a minority of the real bill once instrument licensing, translations, device provisioning and services are added, so early budget estimates are routinely too low.
  • Linguistic validation is charged per instrument per language and is on the critical path to first patient in, so adding a country late in start-up produces both a cost and a schedule hit.
  • Provisioned participant devices bring logistics, replacement, shipping and cellular connectivity obligations that persist for the life of the trial and are frequently underestimated.
  • The EDC component is newer than the eCOA heritage, so sponsors with complex data management requirements often keep an incumbent EDC and lose the single-database benefit that justifies the platform.
  • It is priced and scoped for sponsor-grade trials, which makes it a poor fit for investigator-initiated or academic studies that need outcome collection without the services layer.

Pricing, plan by plan

Fujifilm Synapse

On request
  • Synapse$undefined/year
    • Each module licensed separately: PACS, VNA, Cardiovascular, 3D
    • Priced by annual study volume and concurrent diagnostic users
    • Synapse 3D licensed by concurrent user, separate from PACS

Signant Health

On request
  • SmartSignals Unified Platform$undefined/year
    • Priced per study through a sales process
    • Modules selected per protocol: EDC, eCOA, randomisation, eConsent, TeleVisits
    • Instrument licensing paid to scale owners on top of platform cost

Which should you pick?

Choose Fujifilm Synapse if

  • You need synapse pacs.
  • You work on Web, Windows, iOS, Android.
  • You also want synapse vna.
Fujifilm Synapse review

Choose Signant Health if

  • You need ecoa and epro.
  • You work on Web, iOS, Android.
  • You also want unified platform.
Signant Health review

Questions people ask

Is Fujifilm Synapse or Signant Health better?
Neither clearly leads. Fujifilm Synapse starts at On request and Signant Health at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Fujifilm Synapse or Signant Health?
Fujifilm Synapse starts at On request and Signant Health at On request.
Does Fujifilm Synapse or Signant Health run on more platforms?
Fujifilm Synapse runs on Web, Windows, iOS, Android. Signant Health runs on Web, iOS, Android.
What is Fujifilm Synapse best used for?
Fujifilm Synapse is most often used for a hospital replacing pacs that wants the archive decoupled from its scanner vendor so future modality purchases stay competitive, a health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policy, an outpatient imaging chain that needs one worklist across multiple sites and radiologists reading remotely, a site pursuing a deconstructed pacs strategy that wants to replace the viewer later without touching the archive. Of those, a hospital replacing pacs that wants the archive decoupled from its scanner vendor so future modality purchases stay competitive and a health system consolidating radiology, cardiology, ophthalmology and wound images into one vendor neutral archive with a single retention policy are not what Signant Health is typically brought in for.
What can Fujifilm Synapse do that Signant Health cannot?
Fujifilm Synapse covers Synapse PACS, Synapse VNA, Synapse Cardiovascular, Synapse 3D. Signant Health covers eCOA and ePRO, Unified platform, eConsent, Randomisation and supplies.

Answered from the vendors’ own pages

Fujifilm Synapse: Is Synapse one product or several?

Several. Synapse PACS, Synapse VNA, Synapse Cardiovascular and Synapse 3D are separately licensed products under one brand. Price and scope each one individually.

Signant Health: What is Signant best at?

Electronic clinical outcome assessment, particularly rated scales in central nervous system and psychiatry trials, together with rater training and endpoint quality services.

Fujifilm Synapse: Do I have to buy Fujifilm scanners?

No. Fujifilm sells Synapse independently of imaging hardware, which is a large part of why it wins competitive PACS replacements at mixed fleet sites.

Signant Health: Is pricing published?

No. Everything is quoted per study, and instrument licences, translations and devices sit on top of the platform cost.

Fujifilm Synapse: Does Synapse publish pricing?

No. Pricing is quoted by study volume, concurrent users, module mix and storage capacity.

Signant Health: Can I use it only for eCOA?

Yes. The modules are selected per protocol, and many sponsors take eCOA and eConsent while keeping an existing EDC.

Fujifilm Synapse: Can Synapse VNA store non radiology images?

Yes, including visible light, ophthalmology and wound photography, but each specialty typically needs its own ingestion and metadata configuration project.

Signant Health: What drives the timeline?

Translation and linguistic validation of outcome instruments, which is per language per instrument and sits on the critical path to study start.

Share

Related pages

More on Fujifilm Synapse

More on Signant Health

Keep looking

Other head to heads